Elevance Health Inc. Q1 2026 Earnings Call Summary
Elevance Health Inc. reported strong Q1 2026 performance driven by favorable claims experience and nonrecurring investment income. The company is investing in AI to improve operational efficiency and expects Medicare Advantage to achieve a 2% operating margin in 2026. Management reaffirmed its 2027 adjusted EPS growth target of at least 12%.
Tickers: $ELV
Topics: AI Implementation Capital Deployment Earnings Call Financial Performance Medicaid Medicare Advantage